These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34502215)

  • 1. p53 Activation in Genetic Disorders: Different Routes to the Same Destination.
    Tsai YY; Su CH; Tarn WY
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of p53 in developmental syndromes.
    Bowen ME; Attardi LD
    J Mol Cell Biol; 2019 Mar; 11(3):200-211. PubMed ID: 30624728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
    Bursac S; Brdovcak MC; Donati G; Volarevic S
    Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds.
    Temaj G; Chichiarelli S; Telkoparan-Akillilar P; Saha S; Nuhii N; Hadziselimovic R; Saso L
    Biochem Pharmacol; 2024 Aug; 226():116332. PubMed ID: 38830426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 upregulation is a frequent response to deficiency of cell-essential genes.
    Danilova N; Kumagai A; Lin J
    PLoS One; 2010 Dec; 5(12):e15938. PubMed ID: 21209837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peering through zebrafish to understand inherited bone marrow failure syndromes.
    Oyarbide U; Topczewski J; Corey SJ
    Haematologica; 2019 Jan; 104(1):13-24. PubMed ID: 30573510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.
    Carrillo J; González A; Manguán-García C; Pintado-Berninches L; Perona R
    Clin Transl Oncol; 2014 Jun; 16(6):529-38. PubMed ID: 24065372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
    Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
    Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate p53 activation during development induces features of CHARGE syndrome.
    Van Nostrand JL; Brady CA; Jung H; Fuentes DR; Kozak MM; Johnson TM; Lin CY; Lin CJ; Swiderski DL; Vogel H; Bernstein JA; Attié-Bitach T; Chang CP; Wysocka J; Martin DM; Attardi LD
    Nature; 2014 Oct; 514(7521):228-32. PubMed ID: 25119037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aging or tumor: the crosstalk between telomerase and p53].
    Zhang XF; Tang WR; Luo Y
    Yi Chuan; 2009 May; 31(5):451-6. PubMed ID: 19586837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.
    Rybanska I; Ishaq O; Chou J; Prakash M; Bakhsheshian J; Huso DL; Franco S
    Oncogene; 2013 Apr; 32(14):1761-71. PubMed ID: 22614020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects.
    Bowen ME; Mulligan AS; Sorayya A; Attardi LD
    Cell Death Differ; 2021 Jul; 28(7):2083-2094. PubMed ID: 33574585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere dysfunction: multiple paths to the same end.
    Harrington L; Robinson MO
    Oncogene; 2002 Jan; 21(4):592-7. PubMed ID: 11850784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response.
    Roy S; Roy S; Rana A; Akhter Y; Hande MP; Banerjee B
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):89-97. PubMed ID: 30389168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice.
    Safdar A; Khrapko K; Flynn JM; Saleem A; De Lisio M; Johnston AP; Kratysberg Y; Samjoo IA; Kitaoka Y; Ogborn DI; Little JP; Raha S; Parise G; Akhtar M; Hettinga BP; Rowe GC; Arany Z; Prolla TA; Tarnopolsky MA
    Skelet Muscle; 2016; 6():7. PubMed ID: 26834962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice
    Cai Y; Liu H; Song E; Wang L; Xu J; He Y; Zhang D; Zhang L; Cheng KK; Jin L; Wu M; Liu S; Qi D; Zhang L; Lopaschuk GD; Wang S; Xu A; Xia Z
    Theranostics; 2021; 11(10):4710-4727. PubMed ID: 33754023
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
    Jafarnejad SM; Li G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor p53 and its mutants in cancer metabolism.
    Liu J; Zhang C; Hu W; Feng Z
    Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control of human p53-regulated genes.
    Riley T; Sontag E; Chen P; Levine A
    Nat Rev Mol Cell Biol; 2008 May; 9(5):402-12. PubMed ID: 18431400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.